CASIA OpenIR  > 中国科学院分子影像重点实验室
Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy
Shao, Lizhi1,2; Yan, Ye3; Liu, Zhenyu2,9,12; Ye, Xiongjun4; Xia, Haizhui3; Zhu, Xuehua3; Zhang, Yuting3; Zhang, Zhiying3; Chen, Huiying5; He, Wei5; Liu, Cheng3; Lu, Min6; Huang, Yi3; Ma, Lulin3; Sun, Kai2,8; Zhou, Xuezhi2,8; Yang, Guanyu1,7; Lu, Jian3; Tian, Jie2,8,10,11
发表期刊THERANOSTICS
ISSN1838-7640
2020
卷号10期号:22页码:10200-10212
通讯作者Yang, Guanyu(yang.list@seu.edu.cn) ; Lu, Jian(lujian@bjmu.edu.cn) ; Tian, Jie(jie.tian@ia.ac.cn)
摘要Rationale: To reduce upgrading and downgrading between needle biopsy (NB) and radical prostatectomy (RP) by predicting patient-level Gleason grade groups (GGs) of RP to avoid over-and under-treatment. Methods: In this study, we retrospectively enrolled 575 patients from two medical institutions. All patients received prebiopsy magnetic resonance (MR) examinations, and pathological evaluations of NB and RP were available. A total of 12,708 slices of original male pelvic MR images (T2-weighted sequences with fat suppression, T2WI-FS) containing 5405 slices of prostate tissue, and 2,753 tumor annotations (only T2WI-FS were annotated using RP pathological sections as ground truth) were analyzed for the prediction of patient-level RP GGs. We present a prostate cancer (PCa) framework, PCa-GGNet, that mimics radiologist behavior based on deep reinforcement learning (DRL). We developed and validated it using a multi-center format. Results: Accuracy (ACC) of our model outweighed NB results (0.815 [95% confidence interval (CI): 0.773-0.857] vs. 0.437 [95% CI: 0.335-0.539]). The PCa-GGNet scored higher (kappa value: 0.761) than NB (kappa value: 0.289). Our model significantly reduced the upgrading rate by 27.9% (P < 0.001) and downgrading rate by 6.4% (P = 0.029). Conclusions: DRL using MRI can be applied to the prediction of patient-level RP GGs to reduce upgrading and downgrading from biopsy, potentially improving the clinical benefits of prostate cancer oncologic controls.
关键词prostate cancer Gleason grade groups deep reinforcement learning prostate cancer grading magnetic resonance imaging
DOI10.7150/thno.48706
关键词[WOS]GLEASON SCORE ; TARGETED BIOPSY ; CANCER ; CLASSIFICATION ; OPPORTUNITIES ; CONCORDANCE ; VALIDATION ; DIAGNOSIS ; FEATURES ; SYSTEM
收录类别SCI
语种英语
资助项目National Natural Science Foundation of China[81922040] ; National Natural Science Foundation of China[61871004] ; National Natural Science Foundation of China[81930053] ; National Natural Science Foundation of China[81227901] ; National Natural Science Foundation of China[81527805] ; National Natural Science Foundation of China[31571001] ; National Natural Science Foundation of China[61828101] ; National Key Research and Development Program of China[2018YFC0115900] ; Beijing Natural Science Foundation[7182109] ; National Key R&D Program of China[2017YFA0205200] ; Chinese Academy of Sciences[XDB32030200] ; Chinese Academy of Sciences[XDB01030200] ; Chinese Academy of Sciences[QYZDJ-SSW-JSC005] ; Youth Innovation Promotion Association CAS[2019136] ; Key Research and Development Project of Jiangsu Province[BE2018749] ; Southeast University-Nanjing Medical University Cooperative Research Project[2242019K3DN08]
项目资助者National Natural Science Foundation of China ; National Key Research and Development Program of China ; Beijing Natural Science Foundation ; National Key R&D Program of China ; Chinese Academy of Sciences ; Youth Innovation Promotion Association CAS ; Key Research and Development Project of Jiangsu Province ; Southeast University-Nanjing Medical University Cooperative Research Project
WOS研究方向Research & Experimental Medicine
WOS类目Medicine, Research & Experimental
WOS记录号WOS:000596762400001
出版者IVYSPRING INT PUBL
七大方向——子方向分类医学影像处理与分析
引用统计
被引频次:18[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.ia.ac.cn/handle/173211/42732
专题中国科学院分子影像重点实验室
通讯作者Yang, Guanyu; Lu, Jian; Tian, Jie
作者单位1.Southeast Univ, Sch Comp Sci & Engn, Nanjing 211189, Peoples R China
2.Chinese Acad Sci, Inst Automat, CAS Key Lab Mol Imaging, Beijing Key Lab Mol Imaging,State Key Lab Managem, Beijing 100190, Peoples R China
3.Peking Univ Third Hosp, Dept Urol, Beijing, Peoples R China
4.Peking Univ Peoples Hosp, Urol & Lithotripsy Ctr, Beijing, Peoples R China
5.Peking Univ Third Hosp, Dept Radiol, Beijing, Peoples R China
6.Peking Univ Third Hosp, Dept Pathol, Beijing, Peoples R China
7.Southeast Univ, Key Lab Comp Network & Informat Integrat, Minist Educ, LIST, Nanjing, Peoples R China
8.Xidian Univ, Sch Life Sci & Technol, Minist Educ, Engn Res Ctr Mol & Neuro Imaging, Xian, Peoples R China
9.Chinese Acad Sci, Inst Automat, CAS Ctr Excellence Brain Sci & Intelligence Techn, Beijing, Peoples R China
10.Beihang Univ, Beijing Adv Innovat Ctr Big Data Based Precis Med, Sch Med & Engn, Beijing, Peoples R China
11.Beihang Univ, Minist Ind & Informat Technol, Key Lab Big Data Based Precis Med, Beijing, Peoples R China
12.Univ Chinese Acad Sci, Sch Artificial Intelligence, Beijing 100080, Peoples R China
第一作者单位中国科学院自动化研究所
通讯作者单位中国科学院自动化研究所
推荐引用方式
GB/T 7714
Shao, Lizhi,Yan, Ye,Liu, Zhenyu,et al. Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy[J]. THERANOSTICS,2020,10(22):10200-10212.
APA Shao, Lizhi.,Yan, Ye.,Liu, Zhenyu.,Ye, Xiongjun.,Xia, Haizhui.,...&Tian, Jie.(2020).Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy.THERANOSTICS,10(22),10200-10212.
MLA Shao, Lizhi,et al."Radiologist-like artificial intelligence for grade group prediction of radical prostatectomy for reducing upgrading and downgrading from biopsy".THERANOSTICS 10.22(2020):10200-10212.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Shao, Lizhi]的文章
[Yan, Ye]的文章
[Liu, Zhenyu]的文章
百度学术
百度学术中相似的文章
[Shao, Lizhi]的文章
[Yan, Ye]的文章
[Liu, Zhenyu]的文章
必应学术
必应学术中相似的文章
[Shao, Lizhi]的文章
[Yan, Ye]的文章
[Liu, Zhenyu]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。